| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $360.5M | $488.2M | $388.5M |
| YoY Revenue Growth % | -26.2% | +25.7% | — |
| Gross Profit | $174.7M | $240.1M | — |
| Gross Margin % | 48.5% | 49.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $14.1M | $74.7M | $30.0M |
| Operating Margin % | 3.9% | 15.3% | 7.7% |
| Net Income (GAAP) | $1.2M | $39.2M | $84.0M |
| EBITDA (Normalized) | $22.9M | $82.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $108.0M | $61.9M | $7.1M |
| Capital Expenditures (CapEx) | $11.1M | $9.2M | — |
| Free Cash Flow (FCF) | $96.9M | $52.7M | $7.1M |
| FCF Margin % | 26.9% | 10.8% | 1.8% |
| Return on Invested Capital (ROIC %) | 3.0% | 12.4% | — |
| Cash & Short-Term Equivalents | $124.1M | $101.5M | — |
| Total Debt (Short + Long Term) | $109.1M | $112.1M | — |
| Total Stockholders' Equity | $383.2M | $465.3M | — |